CY1119899T1 - Μη αντιπηκτικες γλυκοζαμιnoγλυκανες που εμπεριεχουν επαναλαμβανομενη μοναδα δισακχαριτη και η ιατρικη τους χρηση - Google Patents
Μη αντιπηκτικες γλυκοζαμιnoγλυκανες που εμπεριεχουν επαναλαμβανομενη μοναδα δισακχαριτη και η ιατρικη τους χρησηInfo
- Publication number
- CY1119899T1 CY1119899T1 CY20181100162T CY181100162T CY1119899T1 CY 1119899 T1 CY1119899 T1 CY 1119899T1 CY 20181100162 T CY20181100162 T CY 20181100162T CY 181100162 T CY181100162 T CY 181100162T CY 1119899 T1 CY1119899 T1 CY 1119899T1
- Authority
- CY
- Cyprus
- Prior art keywords
- glucosaminoglycans
- recoverable
- underground
- medical use
- disc unit
- Prior art date
Links
- 229920002683 Glycosaminoglycan Polymers 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161577223P | 2011-12-19 | 2011-12-19 | |
| PCT/SE2012/051433 WO2013095279A1 (en) | 2011-12-19 | 2012-12-19 | Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1119899T1 true CY1119899T1 (el) | 2018-06-27 |
Family
ID=48668970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20181100162T CY1119899T1 (el) | 2011-12-19 | 2018-02-09 | Μη αντιπηκτικες γλυκοζαμιnoγλυκανες που εμπεριεχουν επαναλαμβανομενη μοναδα δισακχαριτη και η ιατρικη τους χρηση |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US9475888B2 (OSRAM) |
| EP (1) | EP2794665B1 (OSRAM) |
| JP (2) | JP6543467B2 (OSRAM) |
| KR (1) | KR102135485B1 (OSRAM) |
| CN (1) | CN104144950B (OSRAM) |
| AU (1) | AU2012354229B2 (OSRAM) |
| BR (1) | BR112014014454B1 (OSRAM) |
| CA (1) | CA2856492C (OSRAM) |
| CL (1) | CL2014001651A1 (OSRAM) |
| CO (1) | CO7061069A2 (OSRAM) |
| CY (1) | CY1119899T1 (OSRAM) |
| DK (1) | DK2794665T3 (OSRAM) |
| ES (1) | ES2656613T3 (OSRAM) |
| HR (1) | HRP20180124T1 (OSRAM) |
| HU (1) | HUE036523T2 (OSRAM) |
| IL (1) | IL232905A (OSRAM) |
| LT (1) | LT2794665T (OSRAM) |
| ME (1) | ME02994B (OSRAM) |
| MX (1) | MX351104B (OSRAM) |
| NO (1) | NO2904345T3 (OSRAM) |
| PL (1) | PL2794665T3 (OSRAM) |
| PT (1) | PT2794665T (OSRAM) |
| RS (1) | RS56874B1 (OSRAM) |
| RU (1) | RU2617764C2 (OSRAM) |
| SI (1) | SI2794665T1 (OSRAM) |
| SM (1) | SMT201800143T1 (OSRAM) |
| WO (1) | WO2013095279A1 (OSRAM) |
| ZA (1) | ZA201403640B (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013095215A1 (en) | 2011-12-19 | 2013-06-27 | Dilaforette Ab | Low anticoagulant heparins |
| MY175743A (en) * | 2012-03-26 | 2020-07-07 | Dilafor Ab | Combination treatment comprising sulphated glycosaminoglycans for inducing labor |
| HK1203370A1 (en) * | 2012-03-26 | 2015-10-30 | 迪乐方有限责任公司 | Method for treatment of labor arrest |
| CA2868403A1 (en) * | 2012-05-08 | 2013-11-14 | Dilafor Ab | Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent |
| GB2515315A (en) * | 2013-06-19 | 2014-12-24 | Dilafor Ab | New Processes |
| CN103788222B (zh) * | 2014-01-08 | 2016-08-31 | 中国科学院昆明植物研究所 | Fuc3S4S取代的低聚糖胺聚糖及其制备方法 |
| JP2017522392A (ja) * | 2014-04-30 | 2017-08-10 | エージェンシー フォー サイエンス，テクノロジー アンド リサーチ | ヘパラン硫酸 |
| CN108424474B (zh) * | 2017-02-15 | 2023-07-25 | 清华大学 | 去抗凝肝素衍生物及其用于炎症性肠病的治疗 |
| BR112022014456A2 (pt) | 2020-02-17 | 2022-09-13 | Dilafor Ab | Tafoxiparina para o tratamento da pré-eclâmpsia |
| EP4272749A1 (en) | 2022-05-03 | 2023-11-08 | Dilafor AB | New medical use of tafoxiparin |
| US20230355658A1 (en) | 2022-05-03 | 2023-11-09 | Dilafor Ab | Medical use of tafoxiparin |
| GB202407366D0 (en) * | 2024-05-23 | 2024-07-10 | Glycos Biomedical Ltd | Preparation of medium molecular weight heparin |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1136620A (en) | 1979-01-08 | 1982-11-30 | Ulf P.F. Lindahl | Heparin fragments having selective anticoagulation activity |
| JPS63246396A (ja) * | 1987-03-31 | 1988-10-13 | Shiseido Co Ltd | モノクロ−ナル抗体 |
| FR2614026B1 (fr) | 1987-04-16 | 1992-04-17 | Sanofi Sa | Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques |
| SE9002550D0 (sv) | 1990-08-01 | 1990-08-01 | Kabivitrum Ab | Heparinfragment |
| SE9003181D0 (sv) | 1990-10-04 | 1990-10-04 | Kabivitrum Ab | Use of heparin fraction |
| US5280016A (en) | 1991-03-29 | 1994-01-18 | Glycomed Incorporated | Non-anticoagulant heparin derivatives |
| US5250519A (en) | 1991-03-29 | 1993-10-05 | Glycomed Incorporated | Non-anticoagulant heparin derivatives |
| JPH0532703A (ja) * | 1991-07-26 | 1993-02-09 | Terumo Corp | 低分子量ヘパリン誘導体の製造法 |
| AU5442594A (en) | 1992-10-13 | 1994-05-09 | Virginia Commonwealth University | Use of non-anticoagulant heparin for treating ischemia/reperfusion injury |
| US5527785A (en) | 1993-05-14 | 1996-06-18 | The Regents Of The University Of California | Selectin receptor modulating compositions |
| US5744457A (en) * | 1995-03-31 | 1998-04-28 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
| GB2299998B (en) * | 1995-03-31 | 1997-03-26 | Hamilton Civic Hospitals Res | Compositions for inhibiting thrombogenesis |
| US5993810A (en) | 1996-03-15 | 1999-11-30 | Lebovitz; Shamir Israel | Method of softening or ripening the cervix of a female mammal using collagenase |
| US5767269A (en) * | 1996-10-01 | 1998-06-16 | Hamilton Civic Hospitals Research Development Inc. | Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics |
| EP0867452A4 (en) | 1996-10-15 | 2000-07-26 | Toray Industries | MATURATION AGENT FOR CERVICAL CHANNELS |
| GB9711443D0 (en) | 1997-06-03 | 1997-07-30 | Leo Pharm Prod Ltd | Chemical suppositions |
| AU1173599A (en) * | 1997-11-20 | 1999-06-15 | Ikuo Yamashina | Low-molecular heparin modification and remedy for skin ulcer |
| US6596705B1 (en) | 1998-02-09 | 2003-07-22 | The Regents Of The University Of California | Inhibition of L-selectin and P-selection mediated binding using heparin |
| EP1059304B1 (en) | 1998-02-26 | 2006-04-26 | Seikagaku Corporation | Novel polysaccharide derivatives, process for the production thereof and medicinal compositions containing the same as the active ingredient |
| US6028061A (en) | 1998-06-18 | 2000-02-22 | Children's Medical Center Corp | Angiogenesis inhibitors and use thereof |
| KR20010030803A (ko) * | 1998-07-31 | 2001-04-16 | 야마야 와따루 | 신규 글리코사미노글리칸 및 이를 함유하는 의약 조성물 |
| JP2002523522A (ja) * | 1998-08-26 | 2002-07-30 | ザ コラボレイティブ グループ，リミテッド． | 非誘導化水溶性ベータ−（１，３）−グルカンのレセプター |
| MXPA02000142A (es) * | 1999-06-30 | 2003-07-21 | Hamilton Civic Hospitals Res | Composiciones de heparina que inhiben los factores de coagulacion asociados con el coagulo. |
| JP4897991B2 (ja) * | 1999-07-23 | 2012-03-14 | ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ | 超低分子量ヘパリン組成物 |
| IT1316986B1 (it) | 2000-01-25 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica. |
| JP4585072B2 (ja) * | 2000-02-29 | 2010-11-24 | 扶桑薬品工業株式会社 | ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物 |
| CA2422059C (en) * | 2000-09-12 | 2012-05-15 | Massachusetts Institute Of Technology | Methods and products related to low molecular weight heparin |
| SE521676C2 (sv) * | 2002-01-02 | 2003-11-25 | Dilafor Ab | Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet |
| WO2003088980A1 (en) | 2002-04-18 | 2003-10-30 | Embury Stephen H | Method and composition for preventing pain in sickle cell patients |
| US8071569B2 (en) | 2002-09-20 | 2011-12-06 | Mousa Shaker A | Oxidized heparin fractions and their use in inhibiting angiogenesis |
| JP2005106694A (ja) * | 2003-09-30 | 2005-04-21 | Mochida Pharmaceut Co Ltd | 敗血症早期検出及び重篤度評価 |
| EP1582531A1 (en) | 2004-03-24 | 2005-10-05 | Aventis Pharma S.A. | Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products |
| US20060040896A1 (en) * | 2004-08-18 | 2006-02-23 | Paringenix, Inc. | Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity |
| US7741311B2 (en) | 2005-01-03 | 2010-06-22 | Shaker Mousa | Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing |
| CA2616230A1 (en) | 2005-07-22 | 2007-02-01 | Trf Pharma, Inc. | Method for treating sickle cell disease and sickle cell disease sequelae |
| WO2007014049A2 (en) * | 2005-07-22 | 2007-02-01 | The Regents Of The University Of California | Heparin compositions and selectin inhibition |
| EP2016394A4 (en) * | 2006-04-04 | 2013-04-24 | Singulex Inc | METHOD AND COMPOSITIONS FOR HIGHLY SENSITIVE ANALYSIS OF MARKERS AND DETECTION OF MOLECULES |
| WO2007140231A2 (en) * | 2006-05-25 | 2007-12-06 | Momenta Pharmaceutical, Inc. | Low molecular weight heparin composition and uses thereof |
| WO2009007224A1 (en) * | 2007-07-10 | 2009-01-15 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Low molecular weight heparin derivatives having neuroprotective activity |
| US8569262B2 (en) | 2007-11-02 | 2013-10-29 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| WO2009059284A2 (en) | 2007-11-02 | 2009-05-07 | Momenta Pharmaceuticals, Inc. | Non-anticoagulant polysaccharide compositions |
| US8592393B2 (en) * | 2007-11-02 | 2013-11-26 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| EP2207811B1 (en) * | 2007-11-02 | 2017-01-04 | Momenta Pharmaceuticals, Inc. | Non-anticoagulant polysaccharide compositions |
| US8445436B2 (en) | 2007-12-03 | 2013-05-21 | Florida State University Research Foundation, Inc. | Oxytocin and melatonin compositions and associated methods for inducing labor |
| EP2281008B1 (en) | 2008-04-04 | 2017-01-04 | University of Utah Research Foundation | Alkylated and sulfated hyaluronan compounds, methods for their preparation and use thereof |
| WO2010111570A1 (en) * | 2009-03-27 | 2010-09-30 | E. I. Du Pont De Nemours And Company | Polyglycerol aldehydes |
| ES2458818T3 (es) | 2009-04-16 | 2014-05-07 | Momenta Pharmaceuticals, Inc. | Métodos para evaluar la actividad de una composición de polisacárido |
| US20120108538A1 (en) | 2009-06-30 | 2012-05-03 | James Beeson | Sulfated polysaccharides having antiplasmodial activity and methods and products for identifying antiplasmodial activity |
| CA2769258A1 (en) * | 2009-07-31 | 2011-02-03 | Bayer Healthcare Llc | Modified factor ix polypeptides and uses thereof |
| US9066991B2 (en) * | 2009-12-22 | 2015-06-30 | Lifebond Ltd. | Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices |
| WO2013095215A1 (en) | 2011-12-19 | 2013-06-27 | Dilaforette Ab | Low anticoagulant heparins |
| HK1203370A1 (en) | 2012-03-26 | 2015-10-30 | 迪乐方有限责任公司 | Method for treatment of labor arrest |
| MY175743A (en) | 2012-03-26 | 2020-07-07 | Dilafor Ab | Combination treatment comprising sulphated glycosaminoglycans for inducing labor |
-
2012
- 2012-12-19 HR HRP20180124TT patent/HRP20180124T1/hr unknown
- 2012-12-19 CA CA2856492A patent/CA2856492C/en active Active
- 2012-12-19 AU AU2012354229A patent/AU2012354229B2/en active Active
- 2012-12-19 WO PCT/SE2012/051433 patent/WO2013095279A1/en not_active Ceased
- 2012-12-19 ME MEP-2018-14A patent/ME02994B/me unknown
- 2012-12-19 RS RS20180155A patent/RS56874B1/sr unknown
- 2012-12-19 CN CN201280062050.1A patent/CN104144950B/zh active Active
- 2012-12-19 RU RU2014129816A patent/RU2617764C2/ru active
- 2012-12-19 DK DK12858809.2T patent/DK2794665T3/da active
- 2012-12-19 PT PT128588092T patent/PT2794665T/pt unknown
- 2012-12-19 EP EP12858809.2A patent/EP2794665B1/en active Active
- 2012-12-19 BR BR112014014454-0A patent/BR112014014454B1/pt active IP Right Grant
- 2012-12-19 LT LTEP12858809.2T patent/LT2794665T/lt unknown
- 2012-12-19 ES ES12858809.2T patent/ES2656613T3/es active Active
- 2012-12-19 MX MX2014007122A patent/MX351104B/es active IP Right Grant
- 2012-12-19 JP JP2014547146A patent/JP6543467B2/ja active Active
- 2012-12-19 SM SM20180143T patent/SMT201800143T1/it unknown
- 2012-12-19 KR KR1020147016676A patent/KR102135485B1/ko active Active
- 2012-12-19 PL PL12858809T patent/PL2794665T3/pl unknown
- 2012-12-19 US US14/366,624 patent/US9475888B2/en active Active
- 2012-12-19 HU HUE12858809A patent/HUE036523T2/hu unknown
- 2012-12-19 SI SI201231138T patent/SI2794665T1/en unknown
-
2013
- 2013-09-27 NO NO13771071A patent/NO2904345T3/no unknown
-
2014
- 2014-05-20 ZA ZA2014/03640A patent/ZA201403640B/en unknown
- 2014-06-01 IL IL232905A patent/IL232905A/en active IP Right Grant
- 2014-06-16 CO CO14129964A patent/CO7061069A2/es unknown
- 2014-06-19 CL CL2014001651A patent/CL2014001651A1/es unknown
-
2018
- 2018-02-09 CY CY20181100162T patent/CY1119899T1/el unknown
- 2018-02-28 JP JP2018034714A patent/JP2018111825A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119899T1 (el) | Μη αντιπηκτικες γλυκοζαμιnoγλυκανες που εμπεριεχουν επαναλαμβανομενη μοναδα δισακχαριτη και η ιατρικη τους χρηση | |
| CY1120197T1 (el) | Ηπαρινες χαμηλης αντιπηκτικης δρασης | |
| CY1124718T1 (el) | Ανθεκτικο στη διασπαση υαλουρονικο χαμηλου μοριακου βαρους με σταυροδεσμους | |
| CY1119660T1 (el) | Antibakthpiakh απο toy στοματος συνθεση | |
| CY1118223T1 (el) | Μεθοδοι θεραπειας του διαβητη με ανταγωνιστες toy dll4 | |
| MX2013005398A (es) | Hidrolizado de colageno para usarse para mejorar la salud de la piel, el cabello y/o uñas de un humano. | |
| TN2010000086A1 (en) | Antiviral composition comprising a sulfated polysaccharide | |
| CY1118222T1 (el) | Συνθεσεις λυασης φαινυλαλανινης αμμωνιας προκαρυωτικων και μεθοδοι αγωγης καρκινου χρησιμοποιωντας συνθεσεις εξ' αυτης | |
| CY1118265T1 (el) | Παραδοση θεραπευτικων παραγοντων στο κνς | |
| CY1118934T1 (el) | Παρασκευη ενεργης ακρως φωσφορυλιωμενης ανθρωπινης ν-ακετυλογαλακτοζαμινης-6-σουλφατασης και χρησεις αυτης | |
| CY1111354T1 (el) | Συστασεις αναστολεα ddp iv | |
| CY1112813T1 (el) | 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων | |
| BR112012016853A2 (pt) | "composições farmacêuticas para administração oral de peptídeos de insulina". | |
| BR112014015940A2 (pt) | composição de novo fármaco de carboidrato para tratamento de doenças humanas | |
| CY1114960T1 (el) | Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου | |
| EA201190283A1 (ru) | Мультивалентный адъювантный дисплей | |
| MY149505A (en) | Hyaluronic acid binary mixtures and therapeutic use thereof | |
| EA201290941A1 (ru) | КОНЪЮГИРОВАННЫЙ ФАКТОР СВЕРТЫВАНИЯ КРОВИ VIIa | |
| BR112012019844A2 (pt) | metodos e composições para melhorar a resistência mecânica dos dentes | |
| NZ624749A (en) | A sulfated polysaccharide compound and the preparation and use thereof | |
| TN2009000275A1 (en) | Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome | |
| CR20110552A (es) | Tratamiento de transtornos resistentes a la insulina | |
| CY1115780T1 (el) | Φαρμακευτικη συνθεση με glycosαμινοglycans και χρηση αυτης για την θεραπεια χρονιων ελκων | |
| PH12014501290A1 (en) | Methods and products to diagnose and treat heatiness | |
| CY1113469T1 (el) | Συνθεσεις για την θεραπεια μιας φλεγμονωδους παθησης αυτο-ανοσιας |